147 related articles for article (PubMed ID: 9157169)
1. Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniae.
Albrecht WE; Papasian CJ; Bamberger DM; Fiorella R; Riddell SW
J Clin Microbiol; 1997 Apr; 35(4):985-7. PubMed ID: 9157169
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
3. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Bell SM; Gatus BJ; Pham JN
Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
[No Abstract] [Full Text] [Related]
4. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Thornsberry C; Burton PH; Vanderhoof BH
Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
[TBL] [Abstract][Full Text] [Related]
5. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
6. A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone.
Figueiredo AM; Connor JD; Severin A; Vaz Pato MV; Tomasz A
Antimicrob Agents Chemother; 1992 Apr; 36(4):886-9. PubMed ID: 1503454
[TBL] [Abstract][Full Text] [Related]
7. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
[No Abstract] [Full Text] [Related]
8. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
10. Homology analysis of 51 penicillin-intermediate
Zhang J; Hu DK; Gao CY; Shen WW; Luo XH; Yu J; Li XY; Jiang XY; Zhu WS; Chen WQ
J Int Med Res; 2020 Jun; 48(6):300060520919061. PubMed ID: 32529912
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Barry AL; Brown SD; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1996 Apr; 15(4):344-6. PubMed ID: 8781889
[TBL] [Abstract][Full Text] [Related]
12. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae.
Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH
Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
Skulnick M; Small GW; Lo P; Patel MP; Porter CR; Low DE; Matsumura S; Mazzulli T
J Clin Microbiol; 1995 Sep; 33(9):2334-7. PubMed ID: 7494023
[TBL] [Abstract][Full Text] [Related]
14. Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone.
Saenz RE; Sanders CV; Aldridge KE; Patel MM
Clin Infect Dis; 1998 Mar; 26(3):762-3. PubMed ID: 9524860
[No Abstract] [Full Text] [Related]
15. Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
Barry AL; Fuchs PC
J Clin Microbiol; 1996 Oct; 34(10):2609-12. PubMed ID: 8880533
[TBL] [Abstract][Full Text] [Related]
16. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
17. Penicillin-resistant Streptococcus pneumoniae.
Hedge DD
S D J Med; 1996 Nov; 49(11):423-4. PubMed ID: 8973136
[No Abstract] [Full Text] [Related]
18. Streptococcus pneumoniae resistance to penicillin and ceftriaxone in a tertiary care center in Saudi Arabia.
Al-Aqeeli AA; Guy ML; Al-Jumaah SA
Saudi Med J; 2002 Apr; 23(4):400-4. PubMed ID: 11953764
[TBL] [Abstract][Full Text] [Related]
19. Increasing incidence of penicillin- and cefotaxime-resistant
Verghese VP; Veeraraghavan B; Jayaraman R; Varghese R; Neeravi A; Jayaraman Y; Thomas K; Mehendale SM
Indian J Med Microbiol; 2017; 35(2):228-236. PubMed ID: 28681811
[TBL] [Abstract][Full Text] [Related]
20. Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Olivier C; Cohen R; Begué P; Floret D
Pediatr Infect Dis J; 2000 Oct; 19(10):1015-7. PubMed ID: 11055609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
